Scarica l'app Stockscreener
0.6156
2.15%
-0.0135
Silo Pharma Inc Borsa (SILO) Ultime notizie
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
SILO Pharma Secures USPTO Approval for Key Patent Enhancing SPC-15 Protection | SILO Stock News - GuruFocus
Silo Pharma receives patent allowance for PTSD treatment technology - Investing.com
Silo Pharma receives patent allowance for PTSD treatment technology By Investing.com - Investing.com Canada
Silo Pharma, Inc. Receives Notice of Allowance for Patent Strengthening SPC-15 Treatment for PTSD - Nasdaq
Silo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial Nears - GlobeNewswire
Breakthrough PTSD Drug Patent: Silo Pharma's Intranasal Treatment Advances Toward Clinical Trials - Stock Titan
Silo Pharma approves purchase of Bitcoin as treasury reserve asset; shares up - MSN
Silo Pharma allocates $1 million to Bitcoin holdings By Investing.com - Investing.com South Africa
Is Silo Pharma moving to BIO Protocol? No - Binance
Silo Pharma's Board Approves $1 Million Bitcoin Purchase as Treasury Reserve Asset; Shares Rise - MarketScreener
Silo Pharma (SILO) Allocates $1 Million for Bitcoin Investment | - GuruFocus
Silo Pharma allocates $1 million to Bitcoin holdings - Investing.com
Silo Pharma stock surges on Bitcoin reserve move - Investing.com
Silo Pharma stock surges on Bitcoin reserve move By Investing.com - Investing.com South Africa
Silo Pharma Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset - The Manila Times
Silo Pharma, Inc. Approves $1 Million Bitcoin Purchase as Treasury Reserve Asset - Nasdaq
Biotech Makes Bold Move: Silo Pharma Commits $1M to Bitcoin as Inflation Shield - Stock Titan
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Why E2open Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket - Benzinga
Silo Pharma's (NASDAQ:SILO) Groundbreaking Therapies Could Change The Treatment Landscape For PTSD, Fibromyalgia, MS & Alzheimer’s - simplywall.st
Silo Pharma advances PTSD treatment with new drug-device study By Investing.com - Investing.com South Africa
Silo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15 - GlobeNewswire
Silo Pharma stock plunges to 52-week low of $0.47 By Investing.com - Investing.com Canada
Silo Pharma teams up with Resyca for IND-supporting intranasal drug-device study of PTSD drug - Seeking Alpha
SiloPharma (SILO) Advances SPC-15 with New Drug-Device Study Agreement | SILO Stock News - GuruFocus
Silo Pharma Collaborates With Resyca for Drug-Device Study of PTSD Drug SPC-15 - marketscreener.com
Silo Pharma advances PTSD treatment with new drug-device study - Investing.com Australia
Breakthrough PTSD Treatment: Silo Pharma's Brain-Targeting Drug Delivery System Heads to FDA - Stock Titan
Silicon Valley - FinancialContent
Silo Pharma Announces Closing of $2 Million Public Offering - GlobeNewswire
Silo Pharma Completes Public Offering, Raises $1.56 Million - TipRanks
Silo Pharma, Inc. Completes Public Offering Raising Approximately $2 Million - Nasdaq
Silo Pharma Announces Closing Of $2 Million Public Offering - marketscreener.com
SEC Form 424B4 filed by Silo Pharma Inc. - Quantisnow
Silo Pharma sets public offering at $0.60 per share and warrant - Investing.com Nigeria
SiloPharma (SILO) Sets $2 Million Public Offering with Warrants - GuruFocus
Silo Pharma Announces Pricing of $2 Million Public Offering - The Manila Times
Silo Pharma, Inc. Prices Public Offering of 3,333,338 Shares with Associated Warrants - Nasdaq
Silo Pharma Announces $2M Offering with 5-Year Warrants: Complete Details of Latest Financing Round - Stock Titan
Silo Pharma advances in PTSD nasal therapy trials By Investing.com - Investing.com Canada
Silo Pharma Retail Buzz Surges On FDA Toxicology Study Plans For PTSD Treatment - Asianet Newsable
Silo Pharma (SILO) Partners with Veloxity Labs for Key Drug Stud - GuruFocus
Silo Pharma advances PTSD treatment study with Veloxity Labs By Investing.com - Investing.com Canada
Silo Pharma (SILO) Partners with Veloxity Labs for Key Drug Study | SILO Stock News - GuruFocus
Silo Pharma advances PTSD treatment study with Veloxity Labs - Investing.com Australia
0.68%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):